A carregar...
Gamma-Delta CAR-T Cells Show CAR-Directed and Independent Activity Against Leukemia
Autologous T cells engineered to express a chimeric antigen receptor (CAR) against the CD19 antigen are in the frontline of contemporary hemato-oncology therapies, leading to high remission rates in B-cell malignancies. Although effective, major obstacles involve the complex and costly individualize...
Na minha lista:
| Publicado no: | Front Immunol |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Frontiers Media S.A.
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7343910/ https://ncbi.nlm.nih.gov/pubmed/32714329 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2020.01347 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|